FDA inspection
Endonovo Therapeutics, Inc.: FDA inspection ending Oct 13, 2022
FDA inspection 1181508 · No Action Indicated (NAI) · Woodland Hills, CA
Key facts
| Inspection ID | 1181508 |
|---|---|
| Firm | Endonovo Therapeutics, Inc. |
| FEI number | 3014308816 |
| Address | 6320 Canoga Ave Fl 15 |
| City | Woodland Hills |
| State | CA |
| ZIP | 91367 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Oct 13, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data